5.82
0.00
(0.00%)
At close: January 23 at 7:00:00 PM EST
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | 6 | 6 |
Avg. Estimate | -- | -- | 987.9M | 496.99M |
Low Estimate | -- | -- | 938M | 411M |
High Estimate | -- | -- | 1.03B | 596M |
Year Ago Sales | -- | -- | 221.98M | 987.9M |
Sales Growth (year/est) | -- | -- | 345.03% | -49.69% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
ASPHF | -- | -- | -- | -- |
S&P 500 | 9.90% | 11.00% | 14.01% | 13.54% |
Related Tickers
2126.HK JW (Cayman) Therapeutics Co. Ltd
1.400
+1.45%
BT3.BE Lineage Cell Therapeutics Inc
0.5850
0.00%
471A.F aTyr Pharma, Inc.
3.4200
+1.18%
CVAC.VI CureVac N.V.
3.6080
-3.84%
1GDA.F Zevra Therapeutics, Inc.
7.40
-3.27%
HQ1.MU Oruka Therapeutics Inc. R
11.80
-3.28%
2Q5.BE Enochian BioSciences Inc
0.8470
-0.12%
PH4.F CStone Pharmaceuticals
0.2860
0.00%
ORN.F Oryzon Genomics S.A.
1.4660
+3.97%
IVBIY Innovent Biologics Inc.
19.15
0.00%